期刊
AMERICAN JOURNAL OF PATHOLOGY
卷 178, 期 3, 页码 1257-1269出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2010.11.050
关键词
-
类别
资金
- Italian Ministry of Health [RFPS-4-631972]
- Progetto a Concorso Fondazione IRCCS Policlinico
- Renal Child Foundation
- Fondazione D'Amico per la Ricerca sulle Malattie Renali
- Fondazione La Nuova Speranza
The metabotropic glutamate (mGlu) receptor 1 (GRM1) has been shown to play an important role in neuronal cells by triggering, through calcium release from intracellular stores, various signaling pathways that finally modulate neuron excitability, synaptic plasticity, and mechanisms of feedback regulation of neurotransmitter release. Herein, we show that Grm1 is expressed in glomerular podocytes and that a glomerular phenotype is exhibited by Grm1(crv4) mice carrying a spontaneous recessive inactivating mutation of the gene. Homozygous Grm1(crv4/crv4) and, to a lesser extent, heterozygous mice show albuminuria, podocyte foot process effacement, and reduced levels of nephrin and other proteins known to contribute to the maintenance of podocyte cell structure. Overall, the present data extend the role of mGlu1 receptor to the glomerular filtration barrier. The regulatory action of mGlu1 receptor in dendritic spine morphology and in the control of glutamate release is well acknowledged in neuronal cells. Analogously, we speculate that mGlu1 receptor may regulate foot process morphology and intercellular signaling in the podocyte. (Am J Palhol 2011, 178:1257-1269; DOI: 10.1016/j.ajpath.2010.11.050)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据